Skip to main navigation Skip to search Skip to main content

Construction and biological characterization of an HB-GAM/FGF-1 chimera for vascular tissue engineering

  • Lian Xue
  • , Apostolos K. Tassiopoulos
  • , Susanne K. Woloson
  • , Daniel L. Stanton
  • , Christine Sullivan
  • , Brian Hampton
  • , Wilson H. Burgess
  • , Howard P. Greisler
  • Department of Veterans Affairs
  • Holland Laboratory for Biomedical Sciences
  • Loyola University Medical Center

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Objective: Cardiovascular tissue engineering approaches to vessel wall restoration have focused on the potent but relatively nonspecific and heparin-dependent mesenchymal cell mitogen fibroblast growth factor 1 (FGF-1). We hypothesized that linking FGF-1 to a sequence likely to bind to cell surface receptors relatively more abundant on endothelial cells (ECs) might induce a relative greater EC bioavailability of the FGF-1. We constructed a heparin-binding growth-associated molecule (HB-GAM)/FGF-1 chimera by linking full-length human HB-GAM to the amino-terminus of human FGF-1β (21-154) and tested its activities on smooth muscle cells (SMCs) and ECs. Methods: Primary canine carotid SMCs and jugular vein ECs were plated in 96-well plates in media containing 10% fetal bovine serum and grown to approximately 80% confluence. After being growth arrested in serum-free media for 24 hours, the cells were exposed to concentration ranges of cytokines and heparin, and proliferation was measured with tritiated-thymidine incorporation. Twenty percent fetal bovine serum was used as positive control, and phosphate-buffered saline was used as negative control. Results: In the presence of heparin the HB-GAM/FGF-1 chimera stimulated less SMC proliferation than did the wild-type FGF-1 with a median effective dose of approximately 0.3 nmol versus approximately 0.1 nmol (P < .001). By contrast, the chimera retained full stimulating activity on EC proliferation with a median effective dose of 0.06 nmol for both cytokines. Unlike the wild-type protein, the chimera possessed heparin-independent activity. In the absence of heparin, the chimera induced dose-dependent EC and SMC proliferation at 0.06 nmol or more compared with the wild-type FGF-1, which stimulated minimal DNA synthesis at 6.0-nmol concentrations. Conclusions: The HB-GAM/FGF-1 chimera displays significantly greater and uniquely heparin-independent mitogenic activity for both cell types, and in the presence of heparin it displays a significantly greater EC specificity.

Original languageEnglish
Article number28710
Pages (from-to)554-560
Number of pages7
JournalJournal of Vascular Surgery
Volume33
Issue number3
DOIs
StatePublished - 2001

Fingerprint

Dive into the research topics of 'Construction and biological characterization of an HB-GAM/FGF-1 chimera for vascular tissue engineering'. Together they form a unique fingerprint.

Cite this